ABSTRACT: Vasomotor and vaginal symptoms are cardinal symptoms of menopause. Vasomotor symptoms can be particularly troubling to women and are the most commonly reported menopausal symptoms, with a reported prevalence of 50–82% among U.S. women who experience natural menopause 1 2. The occurrence of vasomotor symptoms increases during the transition to menopause and peaks approximately 1 year after the final menstrual period 3 4 5. The purpose of this document is to provide evidence-based guidelines for the treatment of vasomotor and vaginal symptoms related to natural and surgical menopause. (Treatment of menopausal symptoms in cancer survivors is discussed in the American College of Obstetricians and Gynecologists’ Practice Bulletin Number 126, Management of Gynecologic Issues in Women With Breast Cancer.)
- Jump to
- Search page
-
Resources
Resources Close
By reading this page you agree to ACOG's Terms and Conditions. Read terms
Nonmembers: Subscribe now to access exclusive ACOG Clinical content, including:
ACOG Clinical is designed for easy and convenient access to the latest clinical guidance for patient care. Developed with members’, physicians’, and women’s health care professionals’ needs in mind, user-friendly features include:
- Easy, advanced search function to find the most relevant guidance
- Enhanced document presentation
- Advanced features and functionality
You’ll find clinical content written and peer reviewed by experts and valuable information that spans guidance on the diagnosis and management of the full spectrum of obstetric and gynecological conditions and clinical management issues.
Note for Life Fellows: Annual membership dues are waived but there is a discounted annual subscription fee of $95 for access to publications such as the Green Journal, Practice Bulletins, and Committee Opinions. Individual subscriptions include print and online access. Subscribe today.
Subscribe
